These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 16720276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library.
    Popkov M, Jendreyko N, Gonzalez-Sapienza G, Mage RG, Rader C, Barbas CF.
    J Immunol Methods; 2004 May; 288(1-2):149-64. PubMed ID: 15183093
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt.
    Imai N, Shikami M, Miwa H, Suganuma K, Hiramatsu A, Watarai M, Satoh A, Itoh M, Imamura A, Mihara H, Nitta M.
    Br J Haematol; 2006 Dec; 135(5):673-82. PubMed ID: 17107349
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibody mimics based on human fibronectin type three domain engineered for thermostability and high-affinity binding to vascular endothelial growth factor receptor two.
    Parker MH, Chen Y, Danehy F, Dufu K, Ekstrom J, Getmanova E, Gokemeijer J, Xu L, Lipovsek D.
    Protein Eng Des Sel; 2005 Sep; 18(9):435-44. PubMed ID: 16087651
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
    Horta BA, Sodero AC, de Alencastro RB.
    J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
    [Abstract] [Full Text] [Related]

  • 14. Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region.
    Fujisawa D, Yamazaki Y, Lomonte B, Morita T.
    Biochem J; 2008 May 01; 411(3):515-22. PubMed ID: 18251716
    [Abstract] [Full Text] [Related]

  • 15. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
    La DS, Belzile J, Bready JV, Coxon A, DeMelfi T, Doerr N, Estrada J, Flynn JC, Flynn SR, Graceffa RF, Harriman SP, Larrow JF, Long AM, Martin MW, Morrison MJ, Patel VF, Roveto PM, Wang L, Weiss MM, Whittington DA, Teffera Y, Zhao Z, Polverino AJ, Harmange JC.
    J Med Chem; 2008 Mar 27; 51(6):1695-705. PubMed ID: 18311900
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance.
    Zhang L, Hannay JA, Liu J, Das P, Zhan M, Nguyen T, Hicklin DJ, Yu D, Pollock RE, Lev D.
    Cancer Res; 2006 Sep 01; 66(17):8770-8. PubMed ID: 16951193
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions.
    Hardy B, Raiter A, Weiss C, Kaplan B, Tenenbaum A, Battler A.
    Peptides; 2007 Mar 01; 28(3):691-701. PubMed ID: 17187899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.